Valute / KURA
KURA: Kura Oncology Inc
6.30
USD
0.14
(2.17%)
Il tasso di cambio KURA ha avuto una variazione del -2.17% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 6.21 e ad un massimo di 6.55.
Segui le dinamiche di Kura Oncology Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KURA News
- Seeking Alpha Kura: Ziftomenib Shift To Newly Diagnosed Mutant AML Patients Bodes Well (NASDAQ:KURA)
- Investing Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US
- Investing Cantor Fitzgerald reiterates overweight rating on Kura Oncology stock
- Investing Kura Oncology stock maintains Overweight rating on AML treatment progress
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing Citizens JMP reiterates Kura Oncology stock rating on positive trial data
- Investing Kura Oncology at Goldman Sachs Conference: Strategic Insights on ZIFTOMENIB
- Investing Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Investing Kura Oncology at Jefferies Conference: Strategic Advancements in AML
- Investing **citizens jmp reiterates market outperform rating on kura oncology stock**
- Investing Leerink Partners reiterates outperform rating for Kura Oncology stock
- Investing Cantor Fitzgerald reiterates overweight rating for Kura Oncology stock
- Investing Kura Oncology at ASCO: Strategic Moves in AML Treatment
- Investing Kura Oncology reports positive trial results for AML treatment
- Investing H.C. WAINWRIGHT REITERATES BUY RATING ON KURA ONCOLOGY STOCK
- Investing Citizens JMP highlights key ASCO presentations
- Investing Kura Oncology at TD Cowen Summit: Strategic Innovations in Menin Inhibitors
- Investing Cantor Fitzgerald maintains Overweight on Kura Oncology stock
- Investing Kura Oncology to Participate in Three Upcoming Investor Conferences
- Seeking Alpha Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX)
- Benzinga Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - American Axle & Mfg Hldgs (NYSE:AXL), Alumis (NASDAQ:ALMS)
- Seeking Alpha Kura Oncology: Market Sees A Tough Road Ahead, But There's An Opportunity
- Seeking Alpha Kura Oncology, Inc. (KURA) Q4 2024 Earnings Call Transcript
Intervallo Giornaliero
6.21
6.55
Intervallo Annuale
5.41
21.57
- Chiusura Precedente
- 6.37
- Apertura
- 6.44
- Bid
- 6.30
- Ask
- 6.60
- Minimo
- 6.21
- Massimo
- 6.55
- Volume
- 2.574 K
- Variazione giornaliera
- -2.17%
- Variazione Mensile
- 9.76%
- Variazione Semestrale
- -18.29%
- Variazione Annuale
- -69.40%
31 luglio, giovedì
11:30
USD
- Agire
- Fcst
- Prev
- 47.999 K
11:30
USD
- Agire
- Fcst
- -68.3%
- Prev
- -1.6%
12:30
USD
- Agire
- Fcst
- 0.4%
- Prev
- 0.2%
12:30
USD
- Agire
- Fcst
- 2.6%
- Prev
- 2.7%
12:30
USD
- Agire
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Agire
- Fcst
- 2.3%
- Prev
- 2.3%
12:30
USD
- Agire
- Fcst
- 0.2%
- Prev
- -0.1%
12:30
USD
- Agire
- Fcst
- 0.7%
- Prev
- -0.4%
12:30
USD
- Agire
- Fcst
- 0.0%
- Prev
- -0.3%
12:30
USD
- Agire
- Fcst
- 0.9%
- Prev
- 0.9%
12:30
USD
- Agire
- Fcst
- 1.0%
- Prev
- 1.2%
12:30
USD
- Agire
- Fcst
- 0.7%
- Prev
- 0.8%
12:30
USD
- Agire
- Fcst
- 224 K
- Prev
- 217 K
12:30
USD
- Agire
- Fcst
- 1.966 M
- Prev
- 1.955 M
12:30
USD
- Agire
- Fcst
- 222.299 K
- Prev
- 224.500 K
13:45
USD
- Agire
- Fcst
- 42.4
- Prev
- 40.4
14:00
USD
- Agire
- Fcst
- 2.3%
- Prev
- 2.0%
14:30
USD
- Agire
- Fcst
- 2 B
- Prev
- 23 B
15:30
USD
- Agire
- Fcst
- Prev
- 4.245%
15:30
USD
- Agire
- Fcst
- Prev
- 4.265%